NO975583L - Fremstilling av et acylert proteinpulver - Google Patents

Fremstilling av et acylert proteinpulver

Info

Publication number
NO975583L
NO975583L NO975583A NO975583A NO975583L NO 975583 L NO975583 L NO 975583L NO 975583 A NO975583 A NO 975583A NO 975583 A NO975583 A NO 975583A NO 975583 L NO975583 L NO 975583L
Authority
NO
Norway
Prior art keywords
protein
preparation
protein powder
acylated protein
acylated
Prior art date
Application number
NO975583A
Other languages
English (en)
Norwegian (no)
Other versions
NO975583D0 (no
Inventor
Jeffrey Clayton Baker
Brian Allen Moser
Warren E Shrader
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO975583D0 publication Critical patent/NO975583D0/no
Publication of NO975583L publication Critical patent/NO975583L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO975583A 1995-06-07 1997-12-03 Fremstilling av et acylert proteinpulver NO975583L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,220 US5700904A (en) 1995-06-07 1995-06-07 Preparation of an acylated protein powder
PCT/US1996/007963 WO1996040730A1 (en) 1995-06-07 1996-06-04 Preparation of an acylated protein powder

Publications (2)

Publication Number Publication Date
NO975583D0 NO975583D0 (no) 1997-12-03
NO975583L true NO975583L (no) 1997-12-03

Family

ID=23923252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975583A NO975583L (no) 1995-06-07 1997-12-03 Fremstilling av et acylert proteinpulver

Country Status (21)

Country Link
US (1) US5700904A (enExample)
EP (1) EP0747391B1 (enExample)
JP (1) JP3844504B2 (enExample)
KR (1) KR19990022590A (enExample)
CN (1) CN1192218A (enExample)
AT (1) ATE263185T1 (enExample)
AU (1) AU703032B2 (enExample)
BR (1) BR9608729A (enExample)
CA (1) CA2223389A1 (enExample)
CZ (1) CZ388197A3 (enExample)
DE (1) DE69631996T2 (enExample)
DK (1) DK0747391T3 (enExample)
EA (1) EA199800042A1 (enExample)
ES (1) ES2216039T3 (enExample)
HU (1) HUP9900877A3 (enExample)
IL (1) IL122460A0 (enExample)
NO (1) NO975583L (enExample)
NZ (1) NZ309371A (enExample)
PL (1) PL323994A1 (enExample)
TR (1) TR199701528T1 (enExample)
WO (1) WO1996040730A1 (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316895D0 (en) 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US5986050A (en) * 1996-12-26 1999-11-16 Poly-Med, Inc. Peracylated proteins and synthetic polypeptides and process for making the same
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
DE69829953T2 (de) * 1997-02-07 2006-03-02 Novo Nordisk A/S Kristallisation von proteinen
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
AU742591B2 (en) * 1997-03-20 2002-01-10 Novo Nordisk A/S Zinc free insulin crystals for use in pulmonary compositions
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
CA2306905A1 (en) * 1997-10-24 1999-05-06 Eli Lilly And Company Fatty acid-acylated insulin analogs
ZA989644B (en) * 1997-10-24 2000-04-25 Lilly Co Eli Insoluble insulen compositions.
ZA989744B (en) * 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
CO4970787A1 (es) 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
EP1396272A1 (en) * 1997-12-23 2004-03-10 Eli Lilly & Company Insoluble Insulin Compositions for Controlling Blood Glucose
US6526675B1 (en) * 1999-06-07 2003-03-04 Roe-Hoan Yoon Methods of using natural products as dewatering aids for fine particles
US6855260B1 (en) * 1999-06-07 2005-02-15 Roe-Hoan Yoon Methods of enhancing fine particle dewatering
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6799682B1 (en) 2000-05-16 2004-10-05 Roe-Hoan Yoon Method of increasing flotation rate
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AU2003226603A1 (en) * 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2003105768A2 (en) 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1617888B1 (en) 2003-04-23 2019-06-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
PT1656372E (pt) 2003-07-30 2013-06-27 Rigel Pharmaceuticals Inc Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
KR101309770B1 (ko) 2004-07-19 2013-09-30 바이오콘 리미티드 인슐린―올리고머 접합체，제형 및 이들의 용도
ES2334046T3 (es) 2004-10-21 2010-03-04 Novo Nordisk A/S Mecanismo de disminucion para pluma regulable.
JP4022595B2 (ja) * 2004-10-26 2007-12-19 コニカミノルタオプト株式会社 撮影装置
US8007754B2 (en) 2005-02-04 2011-08-30 Mineral And Coal Technologies, Inc. Separation of diamond from gangue minerals
JP4979686B2 (ja) 2005-04-24 2012-07-18 ノボ・ノルデイスク・エー／エス 注入デバイス
CN105348203B (zh) 2005-06-08 2018-09-18 里格尔药品股份有限公司 抑制jak途径的组合物和方法
US20070203161A1 (en) * 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
US7741281B2 (en) * 2005-11-03 2010-06-22 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2007098507A2 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
EP1996259B1 (en) 2006-03-10 2012-08-15 Novo Nordisk A/S An injection device and a method of changing a cartridge in the device
CN101400394B (zh) 2006-03-10 2012-07-04 诺沃-诺迪斯克有限公司 具有传动部件的注射装置
ES2656675T3 (es) 2006-03-30 2018-02-28 Valeritas, Inc. Dispositivo de suministro de fluidos de múltiples cartuchos
US8088900B2 (en) 2006-03-30 2012-01-03 Novo Nordisk A/S Two-phase precipitation of proteins
US7714025B2 (en) * 2006-05-10 2010-05-11 Arizona Biomedical Research Commission Modified chalcone compounds as antimitotic agents
DE602007004972D1 (de) 2006-05-16 2010-04-08 Novo Nordisk As Getriebemechanismus für ein injektionsgerät
PL2023982T3 (pl) 2006-05-18 2012-11-30 Novo Nordisk As Urządzenie wstrzykujące ze środkami blokującymi
CA2681023C (en) 2007-03-23 2015-11-03 Novo Nordisk A/S An injection device comprising a locking nut
PT2203181T (pt) 2007-10-16 2018-05-10 Biocon Ltd Uma composição farmacêutica sólida para administração por via oral e o seu processo de fabrico
SG172885A1 (en) 2009-01-23 2011-08-29 Rigel Pharmaceuticals Inc Compositions and methods for inhibition of the jak pathway
CA2782056C (en) 2009-11-25 2021-03-09 Arisgen Sa Mucosal delivery of peptides
RU2672100C2 (ru) 2010-07-28 2018-11-12 Райджел Фармасьютикалз, Инк. Композиции и способы ингибирования пути jak
US9533106B2 (en) 2011-12-29 2017-01-03 Novo Nordisk A/S Torsion-spring based wind-up auto injector pen with dial-up/dial-down mechanism
EP2828241B1 (en) 2012-03-23 2018-09-12 Mateon Therapeutics, Inc. Compositions and methods for inhibition of cathepsins
US11206846B2 (en) 2017-05-02 2021-12-28 Leprino Foods Company High purity alpha lactalbumin and methods of making
BR112020005959A2 (pt) 2017-09-26 2020-10-06 Biocon Biologics India Limited filtração automatizada integrada para separação, lavagem e secagem de cristais de peptídeos
US20220000880A1 (en) 2018-11-01 2022-01-06 Rigel Pharmaceuticals, Inc. Method and composition embodiments for treating acute myeloid leukemia
WO2020243612A1 (en) 2019-05-29 2020-12-03 Rigel Pharmaceuticals, Inc. Method of preventing and treating thrombosis
CN114698370A (zh) 2019-08-08 2022-07-01 里格尔药品股份有限公司 用于治疗细胞因子释放综合征的化合物和方法
JP7681570B2 (ja) 2019-08-14 2025-05-22 ライジェル ファーマシューティカルズ， インコーポレイテッド サイトカイン放出症候群をブロック又は改善する方法
WO2023183377A1 (en) 2022-03-23 2023-09-28 Rigel Pharmaceuticals, Inc. Pyrimid-2-yl-pyrazole compounds as irak inhibitors

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468831A (fr) * 1965-10-05 1967-02-10 Roussel Uclaf Procédé de préparation de nouveaux composés polypeptidiques et produits en résultant
DE1902865A1 (de) * 1968-02-01 1969-09-11 American Home Prod Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
US3591574A (en) * 1968-05-29 1971-07-06 American Home Prod Tri-n-phenylglycyl derivatives of insulin
US3528960A (en) * 1968-10-07 1970-09-15 Lilly Co Eli N-carboxyaroyl insulins
US3823125A (en) * 1969-10-14 1974-07-09 American Home Prod N-aminoacyl-substituted insulins
US3752798A (en) * 1969-12-02 1973-08-14 G Amird Tris-na1,nb1,nepsilonb29 - (3-x-3-oxo - 1-y-prop-1-en-1-yl)(ndelta-(4-z-6-r-pyrimidin - 2 - yl) ornithine b22)-insulins and their preparation
US3869437A (en) * 1970-05-08 1975-03-04 Nat Res Dev Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
US3950517A (en) * 1970-05-08 1976-04-13 National Research Development Corporation Insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
US3864325A (en) * 1971-11-18 1975-02-04 Nat Res Dev (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
BE791949A (fr) * 1971-11-27 1973-05-28 Schering Ag Derives d'insuline, leur preparation et leur utilisation
US3843815A (en) * 1972-02-10 1974-10-22 Gen Foods Corp Inhibiting gel formation in meat-in-gravy products
US3755569A (en) * 1972-07-25 1973-08-28 American Home Prod Acyl substituted insulins
DE2252157C3 (de) * 1972-10-25 1976-03-18 Hoechst Ag Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
NL7314766A (enExample) * 1972-10-31 1974-05-02
DE2253327A1 (de) * 1972-10-31 1974-05-09 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DE2428412A1 (de) * 1974-06-12 1976-01-15 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DE2439296A1 (de) * 1974-08-16 1976-02-26 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
GB1492997A (en) * 1976-07-21 1977-11-23 Nat Res Dev Insulin derivatives
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US4486458A (en) * 1982-09-07 1984-12-04 A. E. Staley Manufacturing Company Non-gelling corn steep liquor
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JPS6255096A (ja) * 1986-06-12 1987-03-10 Nippon Shinyaku Co Ltd 新規な脂肪酸アシル化合物
JPH01254699A (ja) * 1988-04-05 1989-10-11 Kodama Kk インスリン誘導体及びその用途
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
AU8091091A (en) * 1990-07-26 1992-02-18 University Of Iowa Research Foundation, The Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
AU5574094A (en) * 1992-11-30 1994-06-22 Biosignal Kutato-Fejleszto Kft. Polyunsaturated fatty acyl-peptide composition

Also Published As

Publication number Publication date
TR199701528T1 (xx) 1998-03-21
US5700904A (en) 1997-12-23
CA2223389A1 (en) 1996-12-19
JP3844504B2 (ja) 2006-11-15
AU703032B2 (en) 1999-03-11
PL323994A1 (en) 1998-04-27
ATE263185T1 (de) 2004-04-15
NO975583D0 (no) 1997-12-03
EP0747391A2 (en) 1996-12-11
HUP9900877A2 (hu) 1999-07-28
DK0747391T3 (da) 2004-07-19
BR9608729A (pt) 1999-06-29
KR19990022590A (ko) 1999-03-25
CZ388197A3 (cs) 1998-05-13
EP0747391B1 (en) 2004-03-31
JPH11506738A (ja) 1999-06-15
EP0747391A3 (en) 1997-05-21
DE69631996T2 (de) 2005-01-27
CN1192218A (zh) 1998-09-02
IL122460A0 (en) 1998-06-15
DE69631996D1 (de) 2004-05-06
EA199800042A1 (ru) 1998-08-27
MX9709657A (es) 1998-07-31
NZ309371A (en) 1999-09-29
WO1996040730A1 (en) 1996-12-19
HUP9900877A3 (en) 1999-11-29
ES2216039T3 (es) 2004-10-16
AU5951396A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
NO975583L (no) Fremstilling av et acylert proteinpulver
IN181859B (enExample)
MY153718A (en) Formulation of human antibodies for treating tnf-(?) associated disorders
ATE195076T1 (de) Verfahren zur isolierung von haemopnilus influenzae protein-e
ATE174511T1 (de) Stabiler extrakt aus hypericum perforatum l., verfahren zu seiner herstellung und pharmazeutische zubereitungen
MY127603A (en) Method to remove citrate and aluminum from proteins
ES2190794T3 (es) Procedimiento para la preparacion de disoluciones acuosas de dioxido de cloro.
EP0354507A3 (de) Verfahren zur Herstellung von Des-B30-Insulinen und Des-B30-Insulinderivaten
EA199600019A2 (ru) Способ получения метилтиогидроксибутиронитрила
AU5146196A (en) Method of producing solutions of cellulose in water-containi ng tertiary-amin-n-oxides
GR3034970T3 (en) Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
NZ295194A (en) Wine stabilisation, use of mannoproteins
ATE242818T1 (de) Verfahren zur bekämpfung von mikroorganismen in einem zuckerhaltigen, wässrigen prozessmedium
AU7218396A (en) Method and device for providing plasma
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
NO944936L (no) Fremgangsmåte til fjerning av fosfor
NO920163L (no) Hydrolysert vegetabilsk protein og fremstilling av et slikt
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
GR930100408A (el) Μέ?οδος απομόνωσης και κα?αρισμού μεβινολίνης.
MX9701880A (es) Proceso para producir acidos aminocarboxilicos que tienen bajo contenido de sal residual.
NZ335534A (en) Method of identifying potential pharmaceuticals from plant extracts
DE59401724D1 (de) Verfahren zur verringerung des gehalts an halogenhaltigen organischen verbindungen in wässrigen systemen
MD659G2 (ro) Metodă spectrofotometrică de determinare a seleniului
Ricquebourg et al. Biochemical phenomena associated with the process of leaf senescence in plants: a student problem
GR1001287B (el) Μεθοδος παρασκευης φαρμακου για τη θεραπεια των ουλιτιδων.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application